Literature DB >> 12362103

Reinfection rate in children after successful Helicobacter pylori eradication.

Anne Feydt-Schmidt1, Angelika Kindermann, Nikolaos Konstantopoulos, Hans Demmelmair, Antje Ballauff, Annette Findeisen, Sibylle Koletzko.   

Abstract

OBJECTIVES: This study was performed to determine the rate of Helicobacter pylori reinfection after its successful eradication in children living in Germany.
DESIGN: A total of 102 children (48 boys; 31 German and 71 other nationalities; age 1.8-18 years) with a negative (13)C-urea breath test 8 weeks after triple therapy were followed up by a (13)C-urea breath test every 6 months. The cohort included 11 children aged <6 years, 58 children aged > or =6 to 12 years, and 33 children > or =12 years.
RESULTS: The mean duration (+/- standard deviation) of follow-up was 15.5 +/- 11.9 months with a maximum of 4.9 years, representing 132 patient years. Only three children (aged 9.7-14.9 years, one German, two Turkish) tested positive at 6, 12, and 18 months, respectively. The calculated reinfection rate was 2.3% per person per year.
CONCLUSION: The risk of reinfection with H. pylori is low in children living in Germany. There is no evidence that the reinfection rate depends on the age, sex, or nationality of the child. The low reinfection rate indicates that it is unnecessary to screen or treat asymptomatic family members in order to prevent reinfection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12362103     DOI: 10.1097/00042737-200210000-00013

Source DB:  PubMed          Journal:  Eur J Gastroenterol Hepatol        ISSN: 0954-691X            Impact factor:   2.566


  5 in total

1.  Reinfection Rate after Successful Helicobacter pylori Eradication in Children.

Authors:  Mehri Najafi; Mohammad Sobhani; Ahmad Khodadad; Fatemeh Farahmand; Farzaneh Motamed
Journal:  Iran J Pediatr       Date:  2010-03       Impact factor: 0.364

2.  Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy.

Authors:  Min Soo Kim; Nayoung Kim; Sung Eun Kim; Hyun Jin Jo; Cheol Min Shin; Young Soo Park; Dong Ho Lee
Journal:  BMC Gastroenterol       Date:  2013-09-19       Impact factor: 3.067

Review 3.  Novel and Effective Therapeutic Regimens for Helicobacter pylori in an Era of Increasing Antibiotic Resistance.

Authors:  Yi Hu; Yin Zhu; Nong-Hua Lu
Journal:  Front Cell Infect Microbiol       Date:  2017-05-05       Impact factor: 5.293

4.  Impact of Age, Gender, and Addition of Probiotics on Treatment Success for Helicobacter pylori in Children.

Authors:  Noam Weiner; Ron Shaoul
Journal:  Glob Pediatr Health       Date:  2015-10-07

5.  The updated JSPGHAN guidelines for the management of Helicobacter pylori infection in childhood.

Authors:  Seiichi Kato; Toshiaki Shimizu; Shigeru Toyoda; Benjamin D Gold; Shinobu Ida; Takashi Ishige; Shigeru Fujimura; Shigeru Kamiya; Mutsuko Konno; Kentaro Kuwabara; Kosuke Ushijima; Norikazu Yoshimura; Yoshiko Nakayama
Journal:  Pediatr Int       Date:  2020-12       Impact factor: 1.524

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.